Yonsei University Health SystemSeoul, Seoul
Disclosures:
2588 - Benefit of Reirradiation in Recurrent Glioblastoma after Temozolomide-Based Chemoradiation: A Secondary and Updated Analysis of the [BLINDED] Study
Monday, September 30, 202410:45 AM – 12:00 PM ET
3423 - Objective and Interpretable Breast Cosmesis Evaluation with Attention Guided Denoising Diffusion Anomaly Detection Model
Tuesday, October 1, 20244:00 PM – 5:00 PM ET